ASGN Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ASGN Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.98B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.10B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $4.45B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $4.58B | Feb 24, 2025 |
| FY2021 | Dec 31, 2021 | $1.05B | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $1.07B | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $974.90M | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $907.00M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $900.40M | Mar 1, 2022 |
| FY2021 | Sep 30, 2020 | $904.40M | Mar 1, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.15B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.28B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.37B | Feb 24, 2025 |
| FY2021 | Dec 31, 2021 | $313.70M | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $308.70M | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $276.30M | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $243.70M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $240.80M | Mar 1, 2022 |
| FY2021 | Sep 30, 2020 | $236.30M | Mar 1, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $113.50M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $175.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $219.30M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $268.10M | Feb 24, 2025 |
| FY2021 | Dec 31, 2021 | $85.00M | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $212.00M | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $64.20M | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $48.70M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $55.40M | Mar 1, 2022 |
| FY2021 | Sep 30, 2020 | $52.30M | Mar 1, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $230.30M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $304.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $364.10M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $409.50M | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $350.90M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $281.20M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $276.20M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $260.20M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $224.70M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $189.73M | Mar 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $854.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $821.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $844.20M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $895.00M | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $735.80M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $615.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $645.00M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $705.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $592.00M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $565.83M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $327.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $400.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $456.90M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $307.80M | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $193.70M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $424.80M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $313.20M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $287.40M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $196.40M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $199.33M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.80M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $35.30M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $39.90M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $37.50M | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $34.70M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $32.60M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $32.70M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $28.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $24.30M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $27.14M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.68B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.43B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $3.54B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $3.59B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.50B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $3.28B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $2.94B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.69B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.81B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.75B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.65B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.65B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.68B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.64B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $1.69B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.57B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.51B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $818.74M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $883.73M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.80B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.78B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.89B | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $1.90B | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $1.87B | Feb 24, 2025 |
| FY2023 | Dec 31, 2020 | $1.59B | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $1.38B | Feb 27, 2023 |
| FY2021 | Dec 31, 2018 | $1.18B | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $991.40M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $868.90M | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.14B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.89B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.89B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.89B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.57B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $1.42B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.42B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $894.10M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $873.51M | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.10B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.20B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.20B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.17B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $926.30M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $744.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $586.10M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $428.42M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $315.57M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $161.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $205.20M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $175.90M | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $70.30M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $529.60M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $274.40M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $95.20M | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | $41.80M | Mar 1, 2021 |
| FY2020 | Dec 31, 2017 | $36.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $27.10M | Mar 2, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.03B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.04B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.07B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.03B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $1.03B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.03B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.10B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $575.21M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $640.36M | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 24, 2025 |
| FY2021 | Dec 31, 2021 | 1 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 4 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 1 | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | 1 | Mar 1, 2022 |
| FY2021 | Sep 30, 2020 | 1 | Mar 1, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 24, 2025 |
| FY2021 | Dec 31, 2021 | 1 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 3 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 1 | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | 1 | Mar 1, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Mar 1, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 41.70M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 43.80M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 46.70M | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | 49.50M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 51.80M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | 52.90M | Mar 1, 2022 |
| FY2019 | Dec 31, 2019 | 52.90M | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | 52.50M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 52.15M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 52.72M | Mar 1, 2018 |